KURE is trading 3.05% lower at $18.44, with the decline appearing tied mainly to broader risk-off conditions affecting equities and China-linked assets.
- The KraneShares MSCI All China Health Care Index ETF had no clear company-specific announcement emerge on September 24, 2026; U.S. stocks weakened as the 10-year Treasury yield reached 5.14%, raising concerns about persistent inflation and higher-for-longer rates.
- The ETFβs latest reported NAV change was -0.05%, suggesting todayβs move may largely reflect market pricing and sentiment rather than a major portfolio event.